首页 > 最新文献

Investigative and Clinical Urology最新文献

英文 中文
Comparative analysis of health-related quality of life between children with bladder and bowel dysfunction versus lower urinary tract dysfunction and healthy controls. 膀胱和肠道功能障碍儿童与下尿路功能障碍儿童和健康对照组的健康相关生活质量比较分析。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240137
Hirokazu Ikeda, Takahiro Ono, Chisato Oyake, Yuta Oonuki, Yoshitaka Watanabe, Tsuneki Watanabe

Purpose: This study aimed to compare health-related quality of life (HRQoL) between children with bladder and bowel dysfunction (BBD) and lower urinary tract dysfunction (LUTD) alone and healthy controls based on self-report forms and parent-proxy report forms.

Materials and methods: In this retrospective study, clinical records were reviewed. Children with LUTD, with or without bowel dysfunction, and healthy children were included in this study. The dysfunctional voiding scoring system and Rome IV Diagnostic Criteria were used to assess lower urinary tract symptoms. The Rome IV Diagnostic Criteria was also used to evaluate bowel symptoms. The Pediatric Quality of Life Inventory 4.0 (PedsQL) questionnaire was administered to investigate pediatric HRQoL.

Results: Of the total 252 children (mean age, 7.3±2.1 years) who participated in this study, 78 were classified into the BBD group and 174 into the LUTD group. Compared with the control group, the BBD group had significantly lower total PedsQL scores (p<0.001) and psychosocial healthy summary scores (p<0.001). The BBD group had significantly lower emotional functioning scores than the LUTD group (p=0.023). Children with BBD who presented with fecal incontinence (FI) had a significantly lower social functioning score than those without FI (p=0.023).

Conclusions: Children with BBD who present with FI are at higher risk of decreased psychosocial HRQoL, and they require special emotional support. These findings underscore the need for effective treatment and follow-up to improve the HRQoL of children with BBD who presented with FI.

目的:本研究旨在根据自我报告表和家长代理报告表,比较单纯膀胱和肠道功能障碍(BBD)和下尿路功能障碍(LUTD)患儿与健康对照组之间的健康相关生活质量(HRQoL):在这项回顾性研究中,对临床病历进行了审查。研究对象包括患有排尿功能障碍(伴有或不伴有排便功能障碍)的儿童和健康儿童。排尿功能障碍评分系统和罗马 IV 诊断标准用于评估下尿路症状。罗马 IV 诊断标准也用于评估肠道症状。儿科生活质量量表 4.0 (PedsQL) 问卷用于调查儿科 HRQoL:结果:在参与研究的252名儿童(平均年龄为7.3±2.1岁)中,78名儿童被归入BBD组,174名儿童被归入LUTD组。与对照组相比,BBD 组的 PedsQL 总分明显较低(p 结论:患有BBD并伴有FI的儿童社会心理HRQoL下降的风险较高,他们需要特殊的情感支持。这些研究结果表明,需要采取有效的治疗和随访措施,以改善伴有FI的BBD患儿的HRQoL。
{"title":"Comparative analysis of health-related quality of life between children with bladder and bowel dysfunction versus lower urinary tract dysfunction and healthy controls.","authors":"Hirokazu Ikeda, Takahiro Ono, Chisato Oyake, Yuta Oonuki, Yoshitaka Watanabe, Tsuneki Watanabe","doi":"10.4111/icu.20240137","DOIUrl":"10.4111/icu.20240137","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare health-related quality of life (HRQoL) between children with bladder and bowel dysfunction (BBD) and lower urinary tract dysfunction (LUTD) alone and healthy controls based on self-report forms and parent-proxy report forms.</p><p><strong>Materials and methods: </strong>In this retrospective study, clinical records were reviewed. Children with LUTD, with or without bowel dysfunction, and healthy children were included in this study. The dysfunctional voiding scoring system and Rome IV Diagnostic Criteria were used to assess lower urinary tract symptoms. The Rome IV Diagnostic Criteria was also used to evaluate bowel symptoms. The Pediatric Quality of Life Inventory 4.0 (PedsQL) questionnaire was administered to investigate pediatric HRQoL.</p><p><strong>Results: </strong>Of the total 252 children (mean age, 7.3±2.1 years) who participated in this study, 78 were classified into the BBD group and 174 into the LUTD group. Compared with the control group, the BBD group had significantly lower total PedsQL scores (p<0.001) and psychosocial healthy summary scores (p<0.001). The BBD group had significantly lower emotional functioning scores than the LUTD group (p=0.023). Children with BBD who presented with fecal incontinence (FI) had a significantly lower social functioning score than those without FI (p=0.023).</p><p><strong>Conclusions: </strong>Children with BBD who present with FI are at higher risk of decreased psychosocial HRQoL, and they require special emotional support. These findings underscore the need for effective treatment and follow-up to improve the HRQoL of children with BBD who presented with FI.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic hematoma post prostatic urethral lift: A need to be vigilant in high-risk patients. 前列腺尿道上提术后盆腔血肿:高危患者需要提高警惕。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240228
Gautam Shubhankar, Vikas Kumar Panwar, Avin Singhal, Ankur Mittal
{"title":"Pelvic hematoma post prostatic urethral lift: A need to be vigilant in high-risk patients.","authors":"Gautam Shubhankar, Vikas Kumar Panwar, Avin Singhal, Ankur Mittal","doi":"10.4111/icu.20240228","DOIUrl":"10.4111/icu.20240228","url":null,"abstract":"","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing thulium fiber versus high power holmium laser in bilateral same sitting retrograde intrarenal surgery for kidney stones: Results from a multicenter study. 比较铥光纤与高功率钬激光在双侧同坐位逆行肾内手术治疗肾结石中的应用:一项多中心研究的结果。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240185
Chu Ann Chai, Takaaki Inoue, Bhaskar Kumar Somani, Steffi Kar Kei Yuen, Deepak Ragoori, Nariman Gadzhiev, Yiloren Tanidir, Esteban Emiliani, Saeed Bin Hamri, Mohamed Amine Lakmichi, Vaddi Chandramohan, Angelo Naselli, Boyke Soebhali, Mehmet Ilker Gokce, Azimdjon N Tursunkulov, Fernando Ramón de Fata Chillón, Ben Hall Chew, Olivier Traxer, Daniele Castellani, Vineet Gauhar

Purpose: Traditionally, bilateral urolithiasis treatment involved staged interventions due to safety concerns. Recent studies have shown that same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) is effective, with acceptable complication rates. However, there's no clear data on the optimum laser for the procedure. This study aimed to assess outcomes of SSB-RIRS comparing thulium fiber laser (TFL) and high-power holmium:yttrium-aluminum-garnet (Ho:YAG) laser in a multicenter real-world practice.

Materials and methods: Retrospective analysis was conducted on patients undergoing SSB-RIRS from January 2015 to June 2022 across 21 centers worldwide. Three months perioperative and postoperative outcomes were recorded, focusing on complications and stone-free rates (SFR).

Results: A total of 733 patients were included, with 415 in group 1 (Ho:YAG) and 318 in group 2 (TFL). Both groups have similar demographic and stone characteristics. Group 1 had more incidence of symptomatic pain or hematuria (26.5% vs. 10.4%). Operation and lasing times were comparable. The use of baskets was higher in group 1 (47.2% vs. 18.9%, p<0.001). Postoperative complications and length of hospital stay were similar. Group 2 had a higher overall SFR. Multivariate regression analysis indicated that age, presence of stone at the lower pole, and stone diameter were associated with lower odds of being stone-free bilaterally, while TFL was associated with higher odds.

Conclusions: Our study shows that urologists use both lasers equally for SSB-RIRS. Reintervention rates are low, safety profiles are comparable, and single-stage bilateral SFR may be better in certain cases. Bilateral lower pole and large-volume stones have higher chances of residual fragments.

目的:出于安全考虑,双侧尿路结石的治疗历来需要分期干预。最近的研究表明,同坐位双侧逆行肾内手术(SSB-RIRS)效果显著,并发症发生率在可接受范围内。然而,目前还没有关于该手术最佳激光器的明确数据。本研究旨在评估在多中心真实世界实践中,铥光纤激光(TFL)与高功率钬钇铝石榴石(Ho:YAG)激光的SSB-RIRS疗效:对2015年1月至2022年6月在全球21个中心接受SSB-RIRS的患者进行了回顾性分析。记录了三个月的围手术期和术后结果,重点关注并发症和无结石率(SFR):共纳入 733 名患者,其中第一组(Ho:YAG)415 人,第二组(TFL)318 人。两组患者的人口统计学特征和结石特征相似。第一组出现症状性疼痛或血尿的比例更高(26.5% 对 10.4%)。手术和激光时间相当。第1组使用篮子的比例更高(47.2%对18.9%,P结论:我们的研究表明,泌尿科医生在 SSB-RIRS 中使用两种激光器的比例相当。再介入率低,安全性相当,在某些情况下,单级双侧 SFR 可能更好。双侧下极和大体积结石出现残余碎片的几率更高。
{"title":"Comparing thulium fiber versus high power holmium laser in bilateral same sitting retrograde intrarenal surgery for kidney stones: Results from a multicenter study.","authors":"Chu Ann Chai, Takaaki Inoue, Bhaskar Kumar Somani, Steffi Kar Kei Yuen, Deepak Ragoori, Nariman Gadzhiev, Yiloren Tanidir, Esteban Emiliani, Saeed Bin Hamri, Mohamed Amine Lakmichi, Vaddi Chandramohan, Angelo Naselli, Boyke Soebhali, Mehmet Ilker Gokce, Azimdjon N Tursunkulov, Fernando Ramón de Fata Chillón, Ben Hall Chew, Olivier Traxer, Daniele Castellani, Vineet Gauhar","doi":"10.4111/icu.20240185","DOIUrl":"10.4111/icu.20240185","url":null,"abstract":"<p><strong>Purpose: </strong>Traditionally, bilateral urolithiasis treatment involved staged interventions due to safety concerns. Recent studies have shown that same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) is effective, with acceptable complication rates. However, there's no clear data on the optimum laser for the procedure. This study aimed to assess outcomes of SSB-RIRS comparing thulium fiber laser (TFL) and high-power holmium:yttrium-aluminum-garnet (Ho:YAG) laser in a multicenter real-world practice.</p><p><strong>Materials and methods: </strong>Retrospective analysis was conducted on patients undergoing SSB-RIRS from January 2015 to June 2022 across 21 centers worldwide. Three months perioperative and postoperative outcomes were recorded, focusing on complications and stone-free rates (SFR).</p><p><strong>Results: </strong>A total of 733 patients were included, with 415 in group 1 (Ho:YAG) and 318 in group 2 (TFL). Both groups have similar demographic and stone characteristics. Group 1 had more incidence of symptomatic pain or hematuria (26.5% vs. 10.4%). Operation and lasing times were comparable. The use of baskets was higher in group 1 (47.2% vs. 18.9%, p<0.001). Postoperative complications and length of hospital stay were similar. Group 2 had a higher overall SFR. Multivariate regression analysis indicated that age, presence of stone at the lower pole, and stone diameter were associated with lower odds of being stone-free bilaterally, while TFL was associated with higher odds.</p><p><strong>Conclusions: </strong>Our study shows that urologists use both lasers equally for SSB-RIRS. Reintervention rates are low, safety profiles are comparable, and single-stage bilateral SFR may be better in certain cases. Bilateral lower pole and large-volume stones have higher chances of residual fragments.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying infrequent genetic changes in monozygotic twins afflicted with hypospadias via targeted panel sequencing. 通过靶向面板测序鉴定尿道下裂单卵双生子中不常见的基因变化。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20230416
Ja Hye Kim, Kun Suk Kim, Jae Hyeon Han, Dongsu Kim, Chan Hoon Kwak, Jin-Ho Choi, Sang Hoon Song

Purpose: We aimed to identify the genetic causes of hypospadias in children using targeted gene panel sequencing for disorders of sex development (DSD).

Materials and methods: This study included 18 twin boys with hypospadias: seven and two pairs were monozygotic and dizygotic twins, respectively, and six were discordant and three were concordant twins. Targeted gene panel sequencing for 67 known DSD genes was performed. Sequence variants were classified into five different categories, pathogenic, likely pathogenic, variants of uncertain significance, likely benign, and benign, following the American College of Medical Genetics and Genomics Standards and Guidelines.

Results: The mean gestational age and birth weight were 35.3±2.0 weeks and 1.96±0.61 kg, respectively, with seven patients being small for gestational age. Hypospadias was present in 12 patients, with posterior type in 33.3% and anterior type in 66.7%. In three families with twins, both siblings had hypospadias. In addition, cryptorchidism was observed in one subject. Surgical correction of hypospadias was performed at a mean age of 22.1 months. Molecular analysis identified 12 different genetic variants, including two pathogenic mutations in the AMH (p.E389*) and SRD5A2 (p.R246Q) genes, found in subjects with hypospadias, respectively. However, only heterozygous mutations were detected.

Conclusions: This study did not identify a definitive genetic component contributing to the development of hypospadias; however, the findings suggest that intrauterine growth retardation may play a significant role.

目的:我们的目的是利用性发育障碍(DSD)的靶向基因组测序来确定儿童尿道下裂的遗传原因:本研究纳入了18对尿道下裂的双胞胎男孩:其中7对和2对分别是单卵双胞胎和双卵双胞胎,6对是不和双胞胎,3对是同卵双胞胎。对 67 个已知的 DSD 基因进行了靶向基因组测序。根据美国医学遗传学和基因组学学院的标准和指南,序列变异被分为致病、可能致病、意义不确定、可能良性和良性五个不同类别:平均胎龄和出生体重分别为(35.3±2.0)周和(1.96±0.61)千克,其中 7 名患者的胎龄较小。尿道下裂出现在 12 例患者中,后尿道型占 33.3%,前尿道型占 66.7%。在三个双胞胎家庭中,两个兄弟姐妹都患有尿道下裂。此外,还发现一名患者患有隐睾症。尿道下裂手术矫正的平均年龄为 22.1 个月。分子分析发现了 12 种不同的基因变异,包括 AMH(p.E389*)和 SRD5A2(p.R246Q)基因中的两种致病突变,这两种基因分别在尿道下裂患者中发现。然而,只检测到了杂合突变:结论:本研究并未发现尿道下裂发病的明确遗传因素;但研究结果表明,宫内发育迟缓可能在其中扮演重要角色。
{"title":"Identifying infrequent genetic changes in monozygotic twins afflicted with hypospadias via targeted panel sequencing.","authors":"Ja Hye Kim, Kun Suk Kim, Jae Hyeon Han, Dongsu Kim, Chan Hoon Kwak, Jin-Ho Choi, Sang Hoon Song","doi":"10.4111/icu.20230416","DOIUrl":"10.4111/icu.20230416","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to identify the genetic causes of hypospadias in children using targeted gene panel sequencing for disorders of sex development (DSD).</p><p><strong>Materials and methods: </strong>This study included 18 twin boys with hypospadias: seven and two pairs were monozygotic and dizygotic twins, respectively, and six were discordant and three were concordant twins. Targeted gene panel sequencing for 67 known DSD genes was performed. Sequence variants were classified into five different categories, pathogenic, likely pathogenic, variants of uncertain significance, likely benign, and benign, following the American College of Medical Genetics and Genomics Standards and Guidelines.</p><p><strong>Results: </strong>The mean gestational age and birth weight were 35.3±2.0 weeks and 1.96±0.61 kg, respectively, with seven patients being small for gestational age. Hypospadias was present in 12 patients, with posterior type in 33.3% and anterior type in 66.7%. In three families with twins, both siblings had hypospadias. In addition, cryptorchidism was observed in one subject. Surgical correction of hypospadias was performed at a mean age of 22.1 months. Molecular analysis identified 12 different genetic variants, including two pathogenic mutations in the <i>AMH</i> (p.E389*) and <i>SRD5A2</i> (p.R246Q) genes, found in subjects with hypospadias, respectively. However, only heterozygous mutations were detected.</p><p><strong>Conclusions: </strong>This study did not identify a definitive genetic component contributing to the development of hypospadias; however, the findings suggest that intrauterine growth retardation may play a significant role.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation and quantification of composition variability in urinary stone analysis. 尿石分析中成分变异的调查和量化。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240275
Binh Duy Le, Kyung-Jin Oh, Anh Tuan Le, Long Hoang, Ilwoo Park

Purpose: To investigate the variability in urinary stone composition analysis due to sampling and suggest potential solutions.

Materials and methods: We collected 1,135 stone fragments from 149 instances that had undergone a stone removal at Hanoi Medical University Hospital from January 2022 to August 2022. Each fragment was ground into fine powder and divided into separate specimens if the amount was abundant. For composition analyzing every specimen, Fourier transform infrared spectroscopy was performed. The composition of a given fragment was the average of its belonging specimens. The variability in composition was assessed on the fragment level (i.e., between fragments of an instance). We defined an instance as "significantly variable" if the maximum difference in any composition across its belonging fragments was equal to or greater than a given threshold.

Results: On average, there were 7.6±3.3 stone fragments per instance and 2.3±0.5 specimens per fragment. We found that the variability could be substantial on the fragment level. Eighty-nine (69.5%) and 70 (54.7%) out of 128 multiple-component instances were significantly variable if the threshold was set at 20% and 30%, respectively. The variability of an instance on the fragment level was correlated with the size of fragment and the number of components.

Conclusions: Our study demonstrated the significant variability in urinary stone composition and showed that it correlated with the size and the impurity of samples. Mapping denotation while sampling and analyzing as well as reporting the composition of individual fragments could be valuable to reduce potential variability.

目的:研究尿结石成分分析因取样而产生的变异,并提出可能的解决方案:我们从 2022 年 1 月至 2022 年 8 月期间在河内医科大学医院接受结石清除手术的 149 例患者中收集了 1,135 块结石碎片。每块碎石都被磨成细粉,如果数量较多,则分成单独的标本。为了分析每个标本的成分,对其进行了傅立叶变换红外光谱分析。特定碎片的成分是其所属标本的平均值。成分的变异性在片段层面(即一个实例的片段之间)进行评估。如果一个实例所属片段的任何成分的最大差异等于或大于给定的阈值,我们就将该实例定义为 "显著可变":平均而言,每个实例有 7.6±3.3 块石头碎片,每个碎片有 2.3±0.5 个标本。我们发现,在石片层面的差异可能很大。如果阈值分别设定为 20% 和 30%,128 个多组分实例中分别有 89 个(69.5%)和 70 个(54.7%)具有显著的可变性。片段级实例的可变性与片段大小和成分数量相关:我们的研究证明了尿石成分的显著可变性,并表明它与样本的大小和杂质有关。在取样、分析和报告单个片段成分的同时绘制标注,对减少潜在的变异性很有价值。
{"title":"Investigation and quantification of composition variability in urinary stone analysis.","authors":"Binh Duy Le, Kyung-Jin Oh, Anh Tuan Le, Long Hoang, Ilwoo Park","doi":"10.4111/icu.20240275","DOIUrl":"10.4111/icu.20240275","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the variability in urinary stone composition analysis due to sampling and suggest potential solutions.</p><p><strong>Materials and methods: </strong>We collected 1,135 stone fragments from 149 instances that had undergone a stone removal at Hanoi Medical University Hospital from January 2022 to August 2022. Each fragment was ground into fine powder and divided into separate specimens if the amount was abundant. For composition analyzing every specimen, Fourier transform infrared spectroscopy was performed. The composition of a given fragment was the average of its belonging specimens. The variability in composition was assessed on the fragment level (i.e., between fragments of an instance). We defined an instance as \"significantly variable\" if the maximum difference in any composition across its belonging fragments was equal to or greater than a given threshold.</p><p><strong>Results: </strong>On average, there were 7.6±3.3 stone fragments per instance and 2.3±0.5 specimens per fragment. We found that the variability could be substantial on the fragment level. Eighty-nine (69.5%) and 70 (54.7%) out of 128 multiple-component instances were significantly variable if the threshold was set at 20% and 30%, respectively. The variability of an instance on the fragment level was correlated with the size of fragment and the number of components.</p><p><strong>Conclusions: </strong>Our study demonstrated the significant variability in urinary stone composition and showed that it correlated with the size and the impurity of samples. Mapping denotation while sampling and analyzing as well as reporting the composition of individual fragments could be valuable to reduce potential variability.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving intravesical botulinum toxin-A injection technique: Reshaping the needle may benefit more. 改进膀胱内注射 A 型肉毒毒素的技术:重塑针头可能会让更多人受益。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240236
Farooq Hameed, Adeel Anwaar, Riyan Imtiaz Karamat, Mamoona Anwar
{"title":"Improving intravesical botulinum toxin-A injection technique: Reshaping the needle may benefit more.","authors":"Farooq Hameed, Adeel Anwaar, Riyan Imtiaz Karamat, Mamoona Anwar","doi":"10.4111/icu.20240236","DOIUrl":"10.4111/icu.20240236","url":null,"abstract":"","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety evaluation of imidafenacin administered twice daily for continency recovery following radical prostatectomy in prostate cancer patients: Prospective open-label case-controlled randomized trial. 前列腺癌患者根治性前列腺切除术后,每日两次服用咪达那新促进尿失禁恢复的有效性和安全性评估:前瞻性开放标签病例对照随机试验。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240129
Jun Hee Lee, Hyeok Jun Goh, Kisoo Lee, Dong Won Choi, Kwang Min Lee, Soodong Kim

Purpose: This study aims to prospectively analyze the effects of anticholinergic therapy using imidafenacin on detrusor overactivity occurring after robot-assisted radical prostatectomy (RARP).

Materials and methods: Patients were followed-up at outpatient visits 2-4 weeks post-surgery (visit 2) to confirm the presence of urinary incontinence. Those confirmed with urinary incontinence were randomly assigned in a 1:1 ratio to the anticholinergic medication group (imidafenacin 0.1 mg twice daily) or the control group. Patients were followed-up at 1, 3, and 6 months post-surgery for observational assessments, including the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS).

Results: A total of 49 patients (25 in the treatment group and 24 in the control group) were randomized for the study. There were no differences observed between the groups in terms of age, comorbidities, prostate size, or pathological staging. According to the IPSS questionnaire results, there was no statistically significant difference between the medication and control groups (p=0.161). However, when comparing storage and voiding symptoms separately, there was a statistically significant improvement in storage symptom scores (p=0.012). OABSS also revealed statistically significant improvement in symptoms from 3 months post-surgery (p=0.005), which persisted until 6 months post-surgery (IPSS storage: p=0.023, OABSS: p=0.013).

Conclusions: In the case of urinary incontinence that occurs after RARP, even if the function of the intrinsic sphincter is sufficiently preserved, if urinary incontinence persists due to changes in the bladder, pharmacological therapy using imidafenacin can be beneficial in managing urinary incontinence.

目的:本研究旨在前瞻性地分析使用咪达那新进行抗胆碱能治疗对机器人辅助前列腺癌根治术(RARP)后发生的逼尿肌过度活动的影响:患者在手术后 2-4 周(第 2 次就诊)接受门诊随访,以确认是否存在尿失禁。确认有尿失禁的患者按 1:1 的比例随机分配到抗胆碱能药物组(咪达那新 0.1 毫克,每天两次)或对照组。术后1、3和6个月对患者进行随访,进行观察评估,包括国际前列腺症状评分(IPSS)和膀胱过度活动症状评分(OABSS):共有 49 名患者(治疗组 25 人,对照组 24 人)被随机纳入研究。两组患者在年龄、合并症、前列腺大小或病理分期方面均无差异。根据 IPSS 问卷调查结果,药物治疗组和对照组之间没有统计学差异(P=0.161)。不过,如果分别比较储尿症状和排尿症状,储尿症状得分有统计学意义的显著改善(P=0.012)。OABSS也显示,从术后3个月起,症状有了统计学意义上的明显改善(p=0.005),这种改善一直持续到术后6个月(IPSS储尿:p=0.023,OABSS:p=0.013):结论:在RARP术后出现尿失禁的情况下,即使内在括约肌的功能得到了充分的保留,如果由于膀胱的变化而导致尿失禁持续存在,使用咪达那新进行药物治疗对控制尿失禁是有益的。
{"title":"Efficacy and safety evaluation of imidafenacin administered twice daily for continency recovery following radical prostatectomy in prostate cancer patients: Prospective open-label case-controlled randomized trial.","authors":"Jun Hee Lee, Hyeok Jun Goh, Kisoo Lee, Dong Won Choi, Kwang Min Lee, Soodong Kim","doi":"10.4111/icu.20240129","DOIUrl":"10.4111/icu.20240129","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to prospectively analyze the effects of anticholinergic therapy using imidafenacin on detrusor overactivity occurring after robot-assisted radical prostatectomy (RARP).</p><p><strong>Materials and methods: </strong>Patients were followed-up at outpatient visits 2-4 weeks post-surgery (visit 2) to confirm the presence of urinary incontinence. Those confirmed with urinary incontinence were randomly assigned in a 1:1 ratio to the anticholinergic medication group (imidafenacin 0.1 mg twice daily) or the control group. Patients were followed-up at 1, 3, and 6 months post-surgery for observational assessments, including the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS).</p><p><strong>Results: </strong>A total of 49 patients (25 in the treatment group and 24 in the control group) were randomized for the study. There were no differences observed between the groups in terms of age, comorbidities, prostate size, or pathological staging. According to the IPSS questionnaire results, there was no statistically significant difference between the medication and control groups (p=0.161). However, when comparing storage and voiding symptoms separately, there was a statistically significant improvement in storage symptom scores (p=0.012). OABSS also revealed statistically significant improvement in symptoms from 3 months post-surgery (p=0.005), which persisted until 6 months post-surgery (IPSS storage: p=0.023, OABSS: p=0.013).</p><p><strong>Conclusions: </strong>In the case of urinary incontinence that occurs after RARP, even if the function of the intrinsic sphincter is sufficiently preserved, if urinary incontinence persists due to changes in the bladder, pharmacological therapy using imidafenacin can be beneficial in managing urinary incontinence.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390266/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis. 治疗前体重指数对接受一线免疫检查点抑制剂治疗的转移性肾细胞癌患者临床预后的影响:系统综述和荟萃分析。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240052
Kunwoo Lee, Jiwoong Yu, Wan Song, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Minyong Kang

This study aimed to assess the prognostic role of body mass index (BMI) in patients with metastatic renal cell carcinoma (mRCC) treated with first-line immune checkpoint inhibitor (ICI)-based therapy. We searched for relevant studies in the MEDLINE, Embase, and Cochrane Library databases. The initial search yielded 599 records, of which seven articles (2,517 patients) were selected for analysis. Patients with a high BMI had a favorable overall survival (OS) based on hazard ratio (HR) (crude HR 0.69, 95% confidence interval [CI] 0.57-0.83, p<0.0001; adjusted (a)HR 0.75, 95% CI 0.59-0.95, p=0.02), but not relative risk (RR 0.88, 95% CI 0.67-1.16, p=0.37). In the subgroup analysis, patients with a high BMI had better OS in the ICI with tyrosine kinase inhibitor (TKI) subgroup (aHR 0.71, 95% CI 0.55-0.92, p=0.01), while no significant difference was found in the ICI-only subgroup (aHR 1.02, 95% CI 0.56-1.87, p=0.95). Adjusted statistics for progression-free survival (PFS) were assessable in predominantly ICI-only studies and demonstrated a favorable outcome for patients with a low BMI (aHR 1.67, 95% CI 1.14-2.45, p=0.01). In conclusion, the impact of high BMI varies depending on the treatment type, exhibiting a favorable correlation with OS within ICI with TKI subgroup, but indicating an adverse association with PFS in the ICI-only subgroup. Further research is needed to clarify the influence of BMI by stratifying patients into ICI-only and ICI with TKI treatment to provide more insights.

本研究旨在评估体重指数(BMI)在接受一线免疫检查点抑制剂(ICI)治疗的转移性肾细胞癌(mRCC)患者中的预后作用。我们在 MEDLINE、Embase 和 Cochrane Library 数据库中搜索了相关研究。初步搜索结果为599条记录,其中7篇文章(2,517名患者)被选中进行分析。根据危险比(HR)(粗 HR 0.69,95% 置信区间 [CI] 0.57-0.83,p
{"title":"Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis.","authors":"Kunwoo Lee, Jiwoong Yu, Wan Song, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Minyong Kang","doi":"10.4111/icu.20240052","DOIUrl":"10.4111/icu.20240052","url":null,"abstract":"<p><p>This study aimed to assess the prognostic role of body mass index (BMI) in patients with metastatic renal cell carcinoma (mRCC) treated with first-line immune checkpoint inhibitor (ICI)-based therapy. We searched for relevant studies in the MEDLINE, Embase, and Cochrane Library databases. The initial search yielded 599 records, of which seven articles (2,517 patients) were selected for analysis. Patients with a high BMI had a favorable overall survival (OS) based on hazard ratio (HR) (crude HR 0.69, 95% confidence interval [CI] 0.57-0.83, p<0.0001; adjusted (a)HR 0.75, 95% CI 0.59-0.95, p=0.02), but not relative risk (RR 0.88, 95% CI 0.67-1.16, p=0.37). In the subgroup analysis, patients with a high BMI had better OS in the ICI with tyrosine kinase inhibitor (TKI) subgroup (aHR 0.71, 95% CI 0.55-0.92, p=0.01), while no significant difference was found in the ICI-only subgroup (aHR 1.02, 95% CI 0.56-1.87, p=0.95). Adjusted statistics for progression-free survival (PFS) were assessable in predominantly ICI-only studies and demonstrated a favorable outcome for patients with a low BMI (aHR 1.67, 95% CI 1.14-2.45, p=0.01). In conclusion, the impact of high BMI varies depending on the treatment type, exhibiting a favorable correlation with OS within ICI with TKI subgroup, but indicating an adverse association with PFS in the ICI-only subgroup. Further research is needed to clarify the influence of BMI by stratifying patients into ICI-only and ICI with TKI treatment to provide more insights.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunophenotypic and molecular changes during progression of papillary urothelial carcinoma. 乳头状尿路上皮癌发展过程中的免疫表型和分子变化。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20230318
Bohyun Kim, Kwangsoo Kim, Sunah Yang, Kyung Chul Moon

Purpose: Urothelial carcinoma has various molecular subtypes, each with different tumor characteristics. Although it is known that molecular changes occur during tumor progression, little is known about the specifics of these changes. In this study, we performed transcriptional analysis to understand the molecular changes during tumor progression.

Materials and methods: Formalin-fixed, paraffin-embedded tumor tissues were obtained from 12 patients with muscle-invasive bladder cancer (MIBC). The invasive and non-invasive papillary areas were identified in papillary urothelial carcinoma specimens. Immunohistochemistry (IHC) and mRNA sequencing were performed for each tumor area.

Results: Patients with CK5/6-negative and CK20-positive non-invasive papillary areas were selected and classified into the IHC switch subgroup (CK5/6-positive and CK20-negative in the invasive area) and the IHC unchanged subgroup (CK5/6-negative and CK20-positive in the invasive area) according to the IHC results of the invasive area. We identified differences in the mRNA expression between the non-invasive papillary and invasive areas of the papillary MIBC tissue samples. In both the non-invasive papillary and invasive areas, the IHC switch subgroup showed basal subtype gene expression, while the IHC unchanged subgroup demonstrated luminal subtype gene expression.

Conclusions: The non-invasive papillary area showed a gene expression pattern similar to that of the invasive area. Therefore, even if the non-invasive papillary area exhibits a luminal phenotype on IHC, it can have a basal subtype gene expression depending on the invasive area.

目的:尿路上皮癌有多种分子亚型,每种亚型都有不同的肿瘤特征。虽然人们知道肿瘤进展过程中会发生分子变化,但对这些变化的具体情况却知之甚少。在本研究中,我们进行了转录分析,以了解肿瘤进展过程中的分子变化:12例肌浸润性膀胱癌(MIBC)患者的福尔马林固定、石蜡包埋的肿瘤组织。在乳头状尿路上皮癌标本中确定了浸润性和非浸润性乳头区。对每个肿瘤区域进行免疫组化(IHC)和 mRNA 测序:根据浸润区的 IHC 结果,选择了 CK5/6 阴性和 CK20 阳性的非浸润性乳头区患者,并将其分为 IHC 切换亚组(浸润区 CK5/6 阳性和 CK20 阴性)和 IHC 不变亚组(浸润区 CK5/6 阴性和 CK20 阳性)。我们发现乳头状 MIBC 组织样本的非浸润性乳头区和浸润性区的 mRNA 表达存在差异。在非浸润性乳头状区域和浸润性区域,IHC转换亚组显示基底亚型基因表达,而IHC不变亚组显示管腔亚型基因表达:结论:非浸润性乳头区的基因表达模式与浸润区相似。结论:非浸润性乳头区的基因表达模式与浸润区相似,因此,即使非浸润性乳头区在 IHC 上表现为管腔表型,它也可以根据浸润区的情况表现为基底亚型基因表达。
{"title":"Immunophenotypic and molecular changes during progression of papillary urothelial carcinoma.","authors":"Bohyun Kim, Kwangsoo Kim, Sunah Yang, Kyung Chul Moon","doi":"10.4111/icu.20230318","DOIUrl":"10.4111/icu.20230318","url":null,"abstract":"<p><strong>Purpose: </strong>Urothelial carcinoma has various molecular subtypes, each with different tumor characteristics. Although it is known that molecular changes occur during tumor progression, little is known about the specifics of these changes. In this study, we performed transcriptional analysis to understand the molecular changes during tumor progression.</p><p><strong>Materials and methods: </strong>Formalin-fixed, paraffin-embedded tumor tissues were obtained from 12 patients with muscle-invasive bladder cancer (MIBC). The invasive and non-invasive papillary areas were identified in papillary urothelial carcinoma specimens. Immunohistochemistry (IHC) and mRNA sequencing were performed for each tumor area.</p><p><strong>Results: </strong>Patients with CK5/6-negative and CK20-positive non-invasive papillary areas were selected and classified into the IHC switch subgroup (CK5/6-positive and CK20-negative in the invasive area) and the IHC unchanged subgroup (CK5/6-negative and CK20-positive in the invasive area) according to the IHC results of the invasive area. We identified differences in the mRNA expression between the non-invasive papillary and invasive areas of the papillary MIBC tissue samples. In both the non-invasive papillary and invasive areas, the IHC switch subgroup showed basal subtype gene expression, while the IHC unchanged subgroup demonstrated luminal subtype gene expression.</p><p><strong>Conclusions: </strong>The non-invasive papillary area showed a gene expression pattern similar to that of the invasive area. Therefore, even if the non-invasive papillary area exhibits a luminal phenotype on IHC, it can have a basal subtype gene expression depending on the invasive area.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the relationship between earthquake exposure and severity of erectile dysfunction in southern part of Türkiye. 探讨土耳其南部地区地震暴露与勃起功能障碍严重程度之间的关系。
IF 2.5 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-09-01 DOI: 10.4111/icu.20240200
Muharrem Baturu, Ömer Bayrak, Mehmet Öztürk, Yasin Kurt, Ege Can Şerefoğlu

Purpose: This study aimed to explore the impact of psychological stress on erectile dysfunction (ED) in male patients following the Gaziantep-Kahramanmaras earthquake. The investigation aimed to establish correlations between earthquake-induced stress and changes in sexual function using International Index of Erectile Function (IIEF), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7) scores.

Materials and methods: A retrospective analysis was conducted on male ED patients from a Gaziantep urology clinic post-earthquake (March to August 2023). Patients with deteriorated erectile function post-earthquake (group 1) and those with pre-existing ED experiencing worsened symptoms post-earthquake (group 2) were included. Data collected encompassed sexual histories, IIEF scores, laboratory tests, and PHQ-9/GAD-7 evaluations. Patients were also evaluated mild and mild to moderate ED, moderate and severe ED according to IIEF erectile function.

Results: Seventy-six patients were evaluated (24 in group 1 and 52 in group 2). Significant reductions in total IIEF scores (58 to 40 in group 1 and 49 to 33 in group 2) were observed post-earthquake in both groups (p<0.001). PHQ-9/GAD-7 scores was 11.12±3.79/9.34±3.11 in mild and mild to moderate ED and 13.17±3.05/12.14±3.17 in moderate and severe ED (p=0.011, p<0.001, respectively). Negative correlations existed between PHQ-9/GAD-7 scores and IIEF erectile function (p<0.05) and total IIEF (p<0.05).

Conclusions: This research suggests a plausible connection between the Gaziantep-Kahramanmaras earthquake and heightened ED cases. Psychological stress post-earthquake may contribute to worsened ED symptoms. Further investigations are warranted to comprehensively understand the interplay between natural disasters and sexual dysfunction, essential for optimizing patient care in challenging situations.

目的:本研究旨在探讨加济安泰普-卡赫拉曼马拉什地震后心理压力对男性患者勃起功能障碍(ED)的影响。调查旨在利用国际勃起功能指数(IIEF)、患者健康问卷-9(PHQ-9)和广泛性焦虑症-7(GAD-7)评分,确定地震引起的压力与性功能变化之间的相关性:对地震后(2023 年 3 月至 8 月)加济安泰普一家泌尿科诊所的男性 ED 患者进行了回顾性分析。研究对象包括震后勃起功能恶化的患者(第 1 组)和震后症状加重的原有 ED 患者(第 2 组)。收集的数据包括性史、IIEF 评分、实验室检查和 PHQ-9/GAD-7 评估。根据 IIEF 勃起功能,还对患者进行了轻度和轻中度 ED、中度和重度 ED 的评估:76名患者接受了评估(第一组24人,第二组52人)。地震后,两组患者的 IIEF 总分均有显著下降(第一组从 58 分降至 40 分,第二组从 49 分降至 33 分)(p 结论:该研究表明,地震与勃起功能障碍之间可能存在某种联系:这项研究表明,加济安泰普-卡赫拉曼马拉什地震与 ED 病例增加之间存在着合理的联系。地震后的心理压力可能会导致 ED 症状加重。为了全面了解自然灾害与性功能障碍之间的相互作用,我们有必要开展进一步的调查,这对于在具有挑战性的情况下优化患者护理至关重要。
{"title":"Exploring the relationship between earthquake exposure and severity of erectile dysfunction in southern part of Türkiye.","authors":"Muharrem Baturu, Ömer Bayrak, Mehmet Öztürk, Yasin Kurt, Ege Can Şerefoğlu","doi":"10.4111/icu.20240200","DOIUrl":"10.4111/icu.20240200","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore the impact of psychological stress on erectile dysfunction (ED) in male patients following the Gaziantep-Kahramanmaras earthquake. The investigation aimed to establish correlations between earthquake-induced stress and changes in sexual function using International Index of Erectile Function (IIEF), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7) scores.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on male ED patients from a Gaziantep urology clinic post-earthquake (March to August 2023). Patients with deteriorated erectile function post-earthquake (group 1) and those with pre-existing ED experiencing worsened symptoms post-earthquake (group 2) were included. Data collected encompassed sexual histories, IIEF scores, laboratory tests, and PHQ-9/GAD-7 evaluations. Patients were also evaluated mild and mild to moderate ED, moderate and severe ED according to IIEF erectile function.</p><p><strong>Results: </strong>Seventy-six patients were evaluated (24 in group 1 and 52 in group 2). Significant reductions in total IIEF scores (58 to 40 in group 1 and 49 to 33 in group 2) were observed post-earthquake in both groups (p<0.001). PHQ-9/GAD-7 scores was 11.12±3.79/9.34±3.11 in mild and mild to moderate ED and 13.17±3.05/12.14±3.17 in moderate and severe ED (p=0.011, p<0.001, respectively). Negative correlations existed between PHQ-9/GAD-7 scores and IIEF erectile function (p<0.05) and total IIEF (p<0.05).</p><p><strong>Conclusions: </strong>This research suggests a plausible connection between the Gaziantep-Kahramanmaras earthquake and heightened ED cases. Psychological stress post-earthquake may contribute to worsened ED symptoms. Further investigations are warranted to comprehensively understand the interplay between natural disasters and sexual dysfunction, essential for optimizing patient care in challenging situations.</p>","PeriodicalId":14522,"journal":{"name":"Investigative and Clinical Urology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Investigative and Clinical Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1